AzTrials
AzTrials

Edentulous Alveolar RidgeNCT05861388

Bio-HPP vs Cast Co-cr as Implant Framework

A study testing implant placement in people with Edentulous Alveolar Ridge, run by Tanta University.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study was to assess the effect of Bio-Hpp versus Co-Cr custom abutments in fixed-detachable implant-supported mandibular partial dentures clinically and radiographically in Class I Kennedy classification (split-mouth study) Read more about this study

Who is it for?
Ages 40 to 55 yearsHealthy volunteers can take part
Conditions the study is for
Edentulous Alveolar Ridge
What is being tested?
implant placement
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
15 participants
Where
No sites listed yet
Study dates
15 Jan 2017to 22 Jul 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 55 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Mandibular posterior edentulous with the first premolar as the last standing abutment tooth bilaterally.
  • All patients were edentulous for at least 6 months from the last extraction.
  • The bone height of the alveolar ridge was not less than 12 mm above the inferior alveolar canal and the buccolingual width of the alveolar ridge at the prospective implant site was not less than 6 mm.
  • The opposing arch was almost dentulous, and any missing teeth were restored using a fixed partial denture.
  • Adequate interarch space at least 5mm between the opposing dentition and the mandibular edentulous space.
  • Remaining teeth were in good periodontal condition.
  • Maintaining good oral hygiene and were ready to cooperate throughout the study.

Who cannot join

  • Patients with active infection or inflammation or flabby tissue in the areas intended for implant placement.
  • Those patients with systemic diseases that may influence soft or hard tissue healing.
  • Patients with a history of radiation therapy in the head and neck region.
  • Neurological or psychiatric handicap patients that could interfere with good oral hygiene.
  • Heavy smokers and drug abusers.
  • Patients with severe clenching or bruxism.

About this study

Official title: Short Term Comparative Evaluation of Bio-HPP and Cast Cobalt-chromium as a Framework for Implant-supported Prostheses: A Split-mouth Clinical Randomized Study

The purpose of this study was to assess the effect of Bio-Hpp versus Co-Cr custom abutments in fixed-detachable implant-supported mandibular partial dentures clinically and radiographically in Class I Kennedy classification (split-mouth study)

Read the detailed description

Participants with bilateral partial edentulism in the posterior mandible received two implants at the positions of the second premolar and second molar on both sides; one side was restored with BioHpp based screw-retained FDP (test group) and the other side was restored with Co-Cr based screw-retained FDP (control group). All patients were clinically examined at the time of prosthesis insertion, and 6,12 months later for fracture of implant or framework, fracture, or looseness of the screw, veneer chipping, and fractures, modified bleeding index, modified plaque index, peri-implant probing depth, as well as radiographically for marginal bone loss

Being tested
implant placement
Keywords
Bio-HPP, PEEK, Screw-Retained, Implant Framework

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • implant placementProcedure or surgery

    Also called final prosthesis was constructed on the implants

    2 implants were placed at position of lower 2nd premolar and 2nd molar

Study groups in NCT05861388
Study groupRoleWhat they receive
cobalt chrome implant frameworkActive comparatorthe participants received Co-Cr based screw-retained implant supported prosthesis at one side of the lower jaw
Receives: Procedure: implant placement
Bio-Hpp implant frameworkExperimentalThe participants received Bio-Hpp based screw-retained implant-supported prosthesis at the other side
Receives: Procedure: implant placement

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. marginal bone loss around implants

    Marginal bone level was measured from the implant shoulder to the first bone to implant contact on the mesial and distal sides of the implant on digital standardized periapical radiograph using the long cone paralleling technique

    Measured: 12 months

  2. modified plaque index

    Plaque adherent to the implants was quantified at four surfaces: buccal, lingual, mesial, and distal using a plastic periodontal probe after air drying for the implant and gingiva. The four sides for each implant were scored 0-3 according to the following criteria:

    Score 0: No plaque detected. Score 1: Plaque can be detected by running a probe across the marginal surface of the implant.

    Score 2: Plaque can be seen by naked eye. Score 3: Abundance of plaque.

    Measured: 12 months

  3. modified bleeding index

    A plastic periodontal probe was passed along the gingival margin adjacent to the implant and the following scores were given according to Mombelli and Lang Score 0: No bleeding with slight pressure on the mucosa using periodontal probe.

    Score 1: Isolated bleeding spots visible. Score 2: Blood forms a confluent red line on margin. Score 3: Heavy or profuse bleeding

    Measured: 12 months

  4. probing depth

    ., the peri- implant probing pocket depth is measured around the surfaces of the implants in four areas (mid-buccal, mid-lingual, med-mesial, mid-distal) using plastic periodontal probe* which was inserted with light force and parallel to long axis of implant

    Measured: 12 months

Secondary outcomes (1)
  1. mechanical complications

    framework fracture, screw loosening, screw fracture and chipping or fracture of veneer layer

    Measured: 12 months after loading

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 May 2023
  2. Study start15 Jan 2017
  3. Primary completion20 Jan 2019
  4. Study completion22 Jul 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
15 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05861388
Sponsor's protocol ID
Prosth16/06/02
Status last verified
May 2023
First submitted
20 Oct 2021
Last updated
16 May 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing implant placement in people with Edentulous Alveolar Ridge, run by Tanta University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 May 2023. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

marginal bone loss around implants (time frame: 12 months). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 May 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in